Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Director Dwight A. Merriman sold MongoDB common stock in a series of transactions executed under a pre-arranged Rule 10b5-1 trading plan on April 14 and April 16, 2026. The dispositions totaled $2.9 million and were carried out at prices ranging from $235.30 to $253.48. The trades occurred as MongoDB shares trade near $251.17 amid notable year-to-d…
SkyWater Technology CFO Steve Manko sold 84,215 shares on April 14, 2026, for $2.56 million and exercised options to acquire 30,908 shares. The moves occur as SkyWater’s stock has rallied sharply over the past year and the company moves forward with a planned acquisition by IonQ valued at about $1.8 billion. The board has approved a cash retention …
Brian Daniel Webster, Kestra Medical Technologies' president and CEO, sold 15,000 company shares on April 15, 2026, for about $300,670 under a Rule 10b5-1 plan. The transaction followed the company’s third-quarter 2026 results, which showed an EPS miss but revenue and gross margin outperformance. Analysts from BTIG and Piper Sandler maintained bull…
On April 15, 2026, FedEx director Susan C. Schwab completed a sale of 5,795 shares at $369 each for $2.13 million and, on the same day, exercised options to acquire 5,795 shares in two separate option exercises valued at $1.34 million. The transactions leave Schwab with 10,038 shares. Separately, FedEx announced the departure of CFO John Dietrich e…
Tracy B Brightman, FedEx Corp's Executive Vice President and Chief People Officer, sold 16,959 shares of company stock on April 15, 2026, receiving $6,164,156 from the transactions. On that same day she exercised options to buy 11,865 shares at prices between $229.6 and $294.61, representing $2,986,838 in exercised option value. The share sales occ…
Kenneth Sadowsky, a director at The Vita Coco Company, Inc. (NASDAQ: COCO), sold 3,900 shares on April 15, 2026, for roughly $190,827. The transaction, carried out under a pre-arranged Rule 10b5-1 trading plan, reduces his direct holding to 586,566 shares while he retains fully vested options exercisable through January 2, 2030. The sale coincides …
Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC (NYSE: TDG), sold 3,250 shares on April 15, 2026, realizing about $4.99 million, and concurrently exercised options to acquire 3,900 shares. The transactions come as TransDigm reports preliminary quarterly results, closes recent acquisitions, and prices new debt to fund further deals and…
Rivian CEO Robert J. Scaringe sold 21,446 shares of Class A common stock on April 14, 2026, in an automated trade under a Rule 10b5-1 plan, generating about $346,781. The company reported first-quarter deliveries of 10,365 vehicles and is deploying more than 100 repurposed battery packs in a 10 MWh energy storage project at its Illinois factory. An…
Plexus CORP President and CEO Todd P. Kelsey sold 1,500 shares of company stock on April 15, 2026, through an established Rule 10b5-1 trading plan. The transaction totaled $336,130 and was reported to the SEC on April 16, 2026. The move coincides with Plexus shares trading near a 52-week high after an 81% gain over the prior year and follows the co…
Keith D. Larson, General Counsel and Secretary of Venture Global, Inc. (VG), sold 1,111,112 Class A shares on April 15 and 16, 2026 for proceeds of $13,895,733, in transactions executed at prices between $12.3759 and $12.6364 per share. On those same dates he exercised options to purchase an identical number of shares at $0.79 per share. The compan…
Trimble Inc. President and CEO Robert G. Painter executed multiple equity transactions in mid-April, including a sale of 7,500 shares and a larger acquisition that left him with a material net increase in direct and indirect holdings. The moves coincide with Trimble's announced purchase of Document Crunch, recent earnings and guidance updates, and …
Arteris, Inc. Chief Operating Officer Moll Laurent R. disposed of 13,448 shares on April 14, 2026, generating roughly $269,380 in proceeds through sales priced between $19.90 and $20.22. The trade was carried out under a 10b5-1 plan adopted March 12, 2026, and was disclosed in a Form 4 filed with the SEC. The sale occurred while the company’s stock…
Arteris, Inc. director Chitkara Raman sold 5,000 shares on April 14, 2026, for $100,254 as the stock traded close to its 52-week high. The company posted fourth-quarter 2025 results that beat revenue and EPS expectations, while third-party analysis flags the shares as appearing overvalued at current levels.
Verisk Analytics Chief Financial Officer Elizabeth Mann sold 400 shares for $68,628 under a pre-arranged 10b5-1 plan. The company concurrently disclosed a $1 billion senior notes offering and a $1.5 billion share repurchase program while receiving favorable analyst attention and a valuation note from InvestingPro.
Anna Chiara Jones, Intuitive Machines' senior legal executive, sold 4,911 Class A shares at $23.608 apiece on April 15, 2026, in a transaction reported on Form 4. The sale, executed to satisfy tax withholding obligations related to vested restricted stock units, totaled $115,938 and leaves Jones with 204,289 shares. The transaction was reported Apr…
Matthew J. Audette, President and Chief Financial Officer of LPL Financial Holdings Inc. (NASDAQ: LPLA), sold 1,579 shares of common stock on April 14 and 15, 2026, for $518,900 under a Rule 10b5-1 trading plan. The transactions were completed at prices above the current market quote of $312.57 and InvestingPro's Fair Value of $331.15. LPL reported…
Intuitive Machines senior executive Peter McGrath disposed of 24,554 shares of Class A common stock on April 15, 2026, in a transaction that covered tax withholding on vested restricted stock units. The sale totaled $579,670. The company recently won a $180.4 million NASA contract while reporting fourth-quarter fiscal 2025 results below analyst est…
Paul A. Mahon, Executive Vice President and General Counsel of United Therapeutics, executed sales and option exercises on April 16, 2026 under a pre-arranged 10b5-1 plan. The transactions, combined with ongoing regulatory and analyst activity, leave Mahon with 45,172 shares and place UTHR in a complex valuation and corporate-news environment.
Vita Coco Chief Executive Martin Roper sold 50,000 shares of company stock over April 14-15, 2026, realizing $2,502,675 in proceeds while exercising options to acquire an equal number of shares. The transactions leave Roper with substantial direct and indirect holdings as the company trades below its 52-week high but up 61% year-over-year. Analysts…
Alpha & Omega Semiconductor Chief Executive Officer Stephen Chunping Chang disposed of 5,594 shares on April 14, 2026, under a Rule 10b5-1 plan, generating approximately $178,448. The company recently reported a second-quarter fiscal 2026 loss per share and a revenue shortfall versus analyst expectations, while also opening a commercial assembly an…
York Water Co CFO Matthew E. Poff bought a modest stake on April 16, 2026, purchasing 4.12 shares at $29.127 each for $120. The trade comes while the stock is trading near its 52-week low and as the company pursues an underwritten public offering and announces leadership changes on its board and HR function.
Palomar Holdings President Jon Christianson sold 1,937 shares of the company's common stock on April 15, 2026, in multiple trades that generated about $249,142. He simultaneously exercised options to acquire an identical number of shares at $15.00 per share. The firm’s valuation metrics and recent quarterly results are noted by analysts and market …
Noel Bertram Watson, a director at Affirm Holdings (NASDAQ: AFRM), sold 2,000 Class A shares on April 14, 2026, at $55 per share for a $110,000 transaction. Watson now directly holds 38,076 Affirm shares. The trade occurred under a Rule 10b5-1 plan adopted December 2, 2025. The stock has risen to $60.28, a 21.65% gain over the past week. Meanwhile,…
A director at Establishment Labs Holdings Inc. sold 37,500 common shares on April 14, 2026, netting $2.45 million. The transaction was carried out under a Rule 10b5-1 trading arrangement. The company recently posted stronger-than-expected fourth-quarter 2025 results, with improved EPS and revenue, while an analyst raised the price target on the sto…
Simulations Plus Chief Revenue Officer John Anthony DiBella II sold 1,000 shares of common stock on April 15, 2026, at $13.37 per share, generating $13,370. The transaction, executed automatically under a pre-arranged Rule 10b5-1 plan and disclosed on a Form 4 filing, leaves DiBella with 89,140 shares. The stock has since risen to $14.12, a 12.7% g…
